Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

New research suggests that balance and coordination problems in multiple sclerosis may begin when key brain cells slowly run ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Frustrated by past New Year's resolutions, columnist Desiree Lama is setting intentions to help redefine what progress with ...

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Sanofi (SNY) announced on Wednesday that the U.S. FDA issued a complete response letter regarding its marketing application ...

Cold weather can significantly worsen multiple sclerosis symptoms, triggering stiffness, fatigue, and reduced mobility.

The 54-year-old star recalled a phase when she had experienced MS flare-up, a moment she described that felt like her own ...